View Single Post
Old 07-19-2016, 11:58 AM   Nav to Top 
Senior Trader
Biohero's Avatar
Join Date: Jan 2012
Location: Frankfurt
Posts: 283
Favorites: Aapl celg onxx
Rep Power: 111
Reputation: 36
Biohero is on a distinguished road
Default IGXT (MC $32 M) 2 FDA approvals coming + 2 new NDA Filings in 4Q = 10 +Bagger

Undiscovered Intelgenx (IGXT) is definitely one of the most attractive and undervalued stock in the Biotech Sector . The Company has already 2 Drugs approved and another 2 Big Drugs close to FDA approval .BIG Partnership News could come any day for up to 3 Drugs for which IGXT got a Therm Sheet from a Global Pharma Company and there is another partnering discussion ongoing for 2 Drugs (see pipeline chart below) .

IGXT has a ridiculous Market Cap of less than $32 Million which is a Big Joke for a Company with such a MEGA Product Pipeline , this Co has everything to be the next 10 Bagger minimum .GL

Intelgenx (IGXT)

Market Cap: $31.8 Million
Cash: $2.1 Million
Price: $0.49

Burn-Rate: $400k per Quarter
Shares Out : 63.6 Million

•Announced a development and commercialization term sheet with a global pharmaceutical company for up to three products. If entered into, IntelGenx expects the definitive agreement to be finalized in the second quarter of 2016

Product :Rizaport (Migraine)

•European Mktg Approval–November 2015
•Planned USA submission to FDA Q4/2016
•Expected USA launch Q2/2017

Product :Tadalafil (Erectile Dysfunction) a better Oral thin-film version of Blockbuster Drug Cialis
•505(b)(2) USA NDA submission in Q4/2016
•Expected USA launch Q4/2017

Product :Indicated for Opioid Dependence
•Awaiting FDA approval
•According to IMS data, the oral film market for opioid dependence was worth more than $1.4B US in 2014.

Presentation July 2016

Biohero is offline   Rate this post Yes | No Reply With Quote